Sitafloxacin-based third-line rescue regimens forHelicobacter pyloriinfection in Japan

Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan

(2013) Kazunari Murakami et al.   JOURNAL OF GASTROENTEROLOGY

Management ofHelicobacter pyloriinfection—the Maastricht IV/ Florence Consensus Report

(2012) Peter Malfertheiner et al.   GUT

Variability in Prevalence ofHelicobacter pyloriStrains Resistant to Clarithromycin and Levofloxacin in Southern Poland

(2012) Elżbieta Karczewska et al.   Gastroenterology Research and Practice

Efficacy of Sitafloxacin-Based Rescue Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies

(2011) Juntaro Matsuzaki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacologic Aspects of Eradication Therapy for Helicobacter pylori Infection

(2010) Takahisa Furuta et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

Sitafloxacin Activity against Helicobacter pylori Isolates, Including Those with gyrA Mutations

(2009) K. Murakami et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Prevalence of Primary Fluoroquinolone Resistance Among Clinical Isolates ofHelicobacter pyloriat a University Hospital in Southern Taiwan

(2009) Kuei-Hsiang Hung et al.   HELICOBACTER

Second Asia-Pacific Consensus Guidelines forHelicobacter pyloriinfection

(2009) K Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Resistance to metronidazole, clarithromycin and levofloxacin ofHelicobacter pyloribefore and after clarithromycin-based therapy in Taiwan

(2009) Wei-Lun Chang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY